Evidence map›Paper›PMID 32533067›Full record

ArticleScientific reports2020

Clinical and Genetic Characteristics of 18 Patients from 13 Japanese Families with CRX-associated retinal disorder: Identification of Genotype-phenotype Association.

Yu Fujinami-Yokokawa, Kaoru Fujinami, Kazuki Kuniyoshi, Takaaki Hayashi, Shinji Ueno, Atsushi Mizota, Kei Shinoda, Gavin Arno, Nikolas Pontikos, Lizhu Yang and 16 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Pathogenic variants inGenome research · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Genetic dissection of non-syndromic retinitis pigmentosa.Indian journal of ophthalmology · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 7 countries.

Yu Fujinami-Yokokawa *Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, 152-8902, Japan.
Kaoru Fujinami *Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, 152-8902, Japan. k.fujinami@ucl.ac.uk.
Kazuki KuniyoshiDepartment of Ophthalmology, Kindai University Faculty of Medicine, Osaka-Sayama, 589-8511, Japan.
Takaaki HayashiDepartment of Ophthalmology, The Jikei University School of Medicine, Tokyo, 105-8461, Japan.
Shinji UenoDepartment of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Atsushi MizotaDepartment of Ophthalmology, Teikyo University, Tokyo, 173-8605, Japan.
Kei ShinodaDepartment of Ophthalmology, Teikyo University, Tokyo, 173-8605, Japan.
Gavin ArnoLaboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, 152-8902, Japan.
Nikolas PontikosLaboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, 152-8902, Japan.ORCID http://orcid.org/0000-0003-1782-4711
Lizhu YangLaboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, 152-8902, Japan.
Xiao LiuLaboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, 152-8902, Japan.
Hiroyuki SakuramotoDepartment of Ophthalmology, Kindai University Faculty of Medicine, Osaka-Sayama, 589-8511, Japan.
Satoshi KatagiriDepartment of Ophthalmology, The Jikei University School of Medicine, Tokyo, 105-8461, Japan.ORCID http://orcid.org/0000-0001-7787-8194
Kei MizobuchiDepartment of Ophthalmology, The Jikei University School of Medicine, Tokyo, 105-8461, Japan.
Taro KominamiDepartment of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Hiroko TerasakiDepartment of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Natsuko NakamuraLaboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, 152-8902, Japan.
Shuhei KameyaDepartment of Ophthalmology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, 270-1694, Japan.
Kazutoshi YoshitakeDivision of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, 152-8902, Japan.
Yozo MiyakeLaboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, 152-8902, Japan.
Toshihide KuriharaDepartment of Ophthalmology, Keio University School of Medicine, Tokyo, 160-8582, Japan.ORCID http://orcid.org/0000-0002-5457-2720
Kazuo TsubotaDepartment of Ophthalmology, Keio University School of Medicine, Tokyo, 160-8582, Japan.ORCID http://orcid.org/0000-0002-8874-7111
Hiroaki MiyataDepartment of Health Policy and Management, Keio University School of Medicine, Tokyo, Japan.
Takeshi IwataDivision of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, 152-8902, Japan.ORCID http://orcid.org/0000-0003-1447-0081
Kazushige TsunodaLaboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, 152-8902, Japan.
Japan Eye Genetics Consortium
Keio University · JPNovartis (Switzerland) · CHTokyo Medical Center · JPThe University of Tokyo · JPFujita Health University · JPHamamatsu University School of Medicine · JPJikei University School of Medicine · JPNagoya University · JPRIKEN · JPChiba University · JPHokkaido University · JPKindai University · JPNihon University · JPNiigata University · JPRIKEN Center for Integrative Medical Sciences · JPSaitama Medical University · JPThe University of Osaka · JPUniversity of Miyazaki · JPAichi Medical University · JPArmy Medical University · CN

Funding

Department of Health NIHR-BRCFoundation Fighting Blindness CF-CL-0416-0696-UCL
6 · The paper itself

Abstract

Inherited retinal disorder (IRD) is a leading cause of blindness, and CRX is one of a number of genes reported to harbour autosomal dominant (AD) and recessive (AR) causative variants. Eighteen patients from 13 families with CRX-associated retinal disorder (CRX-RD) were identified from 730 Japanese families with IRD. Ophthalmological examinations and phenotype subgroup classification were performed. The median age of onset/latest examination was 45.0/62.5 years (range, 15-77/25-94). The median visual acuity in the right/left eye was 0.52/0.40 (range, -0.08-2.00/-0.18-1.70) logarithm of the minimum angle of resolution (LogMAR) units. There was one family with macular dystrophy, nine with cone-rod dystrophy (CORD), and three with retinitis pigmentosa. In silico analysis of CRX variants was conducted for genotype subgroup classification based on inheritance and the presence of truncating variants. Eight pathogenic CRX variants were identified, including three novel heterozygous variants (p.R43H, p.P145Lfs*42, and p.P197Afs*22). A trend of a genotype-phenotype association was revealed between the phenotype and genotype subgroups. A considerably high proportion of CRX-RD in ADCORD was determined in the Japanese cohort (39.1%), often showing the mild phenotype (CORD) with late-onset disease (sixth decade). Frequently found heterozygous missense variants located within the homeodomain underlie this mild phenotype. This large cohort study delineates the disease spectrum of CRX-RD in the Japanese population.

Indexed as

Genetic Association StudiesPedigreeAdultAgedAged, 80 and overCohort StudiesFemaleHomeodomain ProteinsHumansJapanMaleMiddle AgedRetinal DiseasesTrans-ActivatorsVisual Acuitycone rod homeobox proteinHomeodomain ProteinsTrans-Activators

Identifiers

PMID32533067
PMCPMC7293272
OpenAlexW3035652155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.